文献速递MDS 与骨髓增殖性肿瘤白血病

miR-146a rs2431697 识别继发性骨髓纤维化进展风险更高的骨髓增殖性肿瘤患者

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.
PubMed 文献 · Leukemia · 2020-02-27

该研究在967例MPN患者和600例对照中分析miR-146a相关SNP rs2910164与rs2431697,发现rs2431697 TT基因型与MF相关,尤其与post-PV/ET MF相关(HR=1.5;p<0.05)。232例PV/ET患者随访8.5年,18例(7.8%)进展为MF,TT基因型者无MF生存更短(p=0.01),且为独立预测因素。

要点

  • rs2431697 TT基因型与post-PV/ET MF风险相关(HR=1.5;p<0.05)。
  • TT基因型是MF进展的独立预测因素,不依赖JAK2V617F等位基因负荷。
  • TT基因型患者血浆炎症细胞因子升高,miR-146a低水平通过增加Stat3信号促进MF表型。

核心结论

  • rs2431697 TT基因型是MF进展的早期预测因素,独立于JAK2V617F等位基因负荷。
  • 低水平miR-146a通过增加Stat3信号促进MF表型。

研究设计与样本

  • 在967例MPN患者(320例PV、333例ET、314例MF)和600例对照中分析rs2910164与rs2431697。
  • 对232例PV/ET患者随访8.5年,观察MF进展。
  • 使用miR-146a-/-小鼠观察Stat3活性与MF样表型。

主要发现

  • rs2431697 TT基因型与MF相关,尤其与post-PV/ET MF相关(HR=1.5;p<0.05)。
  • 232例PV/ET患者中18例(7.8%)进展为MF,TT基因型者无MF生存较CC+CT短(p=0.01)。
  • 多因素分析显示TT基因型是MF进展的独立预测因素。
  • TT基因型患者血浆炎症细胞因子升高。
  • miR-146a-/-小鼠随年龄增长Stat3活性显著升高,并出现MF样表型。

关键数值与推荐

  • rs2431697 TT基因型与post-PV/ET MF相关(HR=1.5;p<0.05)。
  • 232例PV/ET患者随访8.5年,18例(7.8%)进展为MF,TT基因型者无MF生存更短(p=0.01)。

临床怎么用

  • 对PV/ET患者可检测rs2431697基因型以识别MF进展高风险者。
  • TT基因型患者应加强MF进展监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelofibrosis (MF) occurs as part of the natural history of polycythemia vera (PV) and essential thrombocythemia (ET), and remarkably shortens survival. Although JAK2V617F and CALR allele burden are the main transformation risk factors, inflammation plays a critical role by driving clonal expansion toward end-stage disease. NF-κB is a key mediator of inflammation-induced carcinogenesis. Here, we explored the involvement of miR-146a, a brake in NF-κB signaling, in MPN susceptibility and progression. rs2910164 and rs2431697, that affect miR-146a expression, were analyzed in 967 MPN (320 PV/333 ET/314 MF) patients and 600 controls. We found that rs2431697 TT genotype was associated with MF, particularly with post-PV/ET MF (HR = 1.5; p < 0.05). Among 232 PV/ET patients (follow-up time=8.5 years), 18 (7.8%) progressed to MF, being MF-free-survival shorter for rs2431697 TT than CC + CT patients (p = 0.01). Multivariate analysis identified TT genotype as independent predictor of MF progression. In addition, TT (vs. CC + CT) patients showed increased plasma inflammatory cytokines. Finally, miR-146a-/- mice showed significantly higher Stat3 activity with aging, parallel to the development of the MF-like phenotype. In conclusion, we demonstrated that rs2431697 TT genotype is an early predictor of MF progression independent of the JAK2V617F allele burden. Low levels of miR-146a contribute to the MF phenotype by increasing Stat3 signaling.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Ferrer-Marín F, Arroyo AB, Bellosillo B, et al. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020. PMID: 32107471. doi:10.1038/s41375-020-0767-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。